ArticleDrug and alcohol dependence2026
Use of sedative drugs among adults reporting illicit opioid use or prescription opioid use in the United States, 2017-2024.
Article in Drug and alcohol dependence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionCo-use of opioids and sedatives significantly increases the risk of overdose. This study examined associations between person-level characteristics and persons who co-use different types of opioids (prescription and/or illicit opioids) and sedatives.
methodsThe study population included a large sample of adults aged ≥ 18 years assessed for substance use disorder treatment in the United States. Data were collected between January 2017 and June 2024 using the Addiction Severity Index-Multimedia Version instrument. Co-use was defined as reporting past 30-day use of both opioids and sedatives. Multivariable Poisson regressions were used to examine associations between person-level characteristics and co-use.
resultsThe percentage of adults reporting sedative co-use was 17.5% among those using prescription opioids only (n = 36,978), 17.5% among those using illicit opioids only (n = 13,492), and 29.9% among those using both prescription and illicit opioid (n = 19,542). Being non-Hispanic White and having psychiatric conditions were associated with increased prevalence of co-use, regardless of opioid type. Adults assessed in the Northeast (adjusted prevalence ratios (aPRs)= 5.88 [95%CI= 4.49-7.97]), or Midwest (aPR=2.52 [95%CI=1.83-3.47]) versus the West were associated with an increased prevalence of co-use of illicit opioids only and sedatives but were not associated with co-use of prescription opioids only and sedatives.
conclusionsFindings provide new insights into co-use of opioids and sedatives and help inform prevention strategies. In addition to checking prescription drug monitoring programs and care coordination, potential opportunities for preventing co-use of illicit opioids and sedatives include disrupting the availability of illicit opioids and checking persons' substance use and overdose history.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.